Market Value129,351,000
Total Holdings52
File Date2016-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Note this is an amended filing that contain additional holdings that were omitted from a previous filing. This is not likely to be an accurate picture of the total holdings of this firm.

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ONCE / Spark Therapeutics, Inc.
AGIO / Agios Pharmaceuticals, Inc.
ISEE / IVERIC bio Inc
MRK / Merck & Co., Inc.
MACK / Merrimack Pharmaceuticals, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
CLVS / Clovis Oncology Inc
SNR / New Senior Investment Group Inc
SIOX / Sio Gene Therapies Inc.
AVDL / Avadel Pharmaceuticals plc
PCRX / Pacira BioSciences, Inc.
PSDV / pSivida Corp.
DRNA / Dicerna Pharmaceuticals Inc
PRTK / Paratek Pharmaceuticals Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
VCEL / Vericel Corporation
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
MDCO / Medicines Company
FLDM / Standard BioTools Inc
SDS / ProShares Trust - ProShares UltraShort S&P500
IWM / iShares Trust - iShares Russell 2000 ETF Put
LOXO / Loxo Oncology, Inc.
451731103 / Ignyta, Inc.
BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology
MDVN / Medivation, Inc.
ADMS / Adamas Pharmaceuticals Inc
MCRB / Seres Therapeutics, Inc.
HOLX / Hologic, Inc.
INCY / Incyte Corporation
KPTI / Karyopharm Therapeutics Inc.
EPZM / Epizyme Inc
BIIB / Biogen Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
QGEN / Qiagen N.V.
PFE / Pfizer Inc.
UTHR / United Therapeutics Corporation
NKTR / Nektar Therapeutics
MTD / Mettler-Toledo International Inc.
IONS / Ionis Pharmaceuticals, Inc.
SGEN / Seagen Inc
BMY / Bristol-Myers Squibb Company
ZGNX / Zogenix Inc
ALKS / Alkermes plc
AMGN / Amgen Inc.
BMRN / BioMarin Pharmaceutical Inc.
ILMN / Illumina, Inc.
CELG / Celgene Corp.
RARE / Ultragenyx Pharmaceutical Inc.
REGN / Regeneron Pharmaceuticals, Inc.
GILD / Gilead Sciences, Inc.
LABU / Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
VRTX / Vertex Pharmaceuticals Incorporated